81 0

Full metadata record

DC FieldValueLanguage
dc.contributor.author최규선-
dc.date.accessioned2020-07-28T06:45:39Z-
dc.date.available2020-07-28T06:45:39Z-
dc.date.issued2019-06-
dc.identifier.citationAMERICAN JOURNAL OF EMERGENCY MEDICINE, v. 37, no. 6, Page. 1101-1107en_US
dc.identifier.issn0735-6757-
dc.identifier.issn1532-8171-
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S073567571830723X?via%3Dihub-
dc.identifier.urihttps://repository.hanyang.ac.kr/handle/20.500.11754/151924-
dc.description.abstractObjective: The purpose of this study was to evaluate the effects of erythropoietin (EPO) on mortality and neurological outcomes in patients with traumatic brain injury (TBI). Materials and methods: Electronic databases of studies published up to January 5, 2017 were searched to retrieve relevant investigations comparing the outcomes of EPO-treated patients and untreated patients following TBI. We calculated the relative risk (RR) of mortality, neurologic outcomes, and deep vein thrombosis (DVI) with corresponding 95% confidence interval (CI) using meta-analysis. Results: Six randomized controlled clinical trials met the eligibility criteria. In total, 1041 patients were included among the studies. EPO was found to significantly reduce the occurrence of mortality (RR 0.68 [95%CI 0.50-0.95]; P = 0.02), but did not significantly reduce poor functional outcome (RR 1.22 [95% CI 0.82-1.81]; P = 0.33). There were no significant differences in the occurrence of complications, such as DVT, between the treatment groups (RR - 0.02 [95% CI - 0.06 0.021; P = 0.81). Conclusions: Results of the present meta-analysis suggest that the use of EPO may prevent death following TBI without causing adverse events, such as deep vein thrombosis. However, the role of EPO in improving neurological outcome(s) remains unclear. Further well-designed, randomized controlled trials using modified protocols and involving specific patient populations are required to clarify this issue, and to verify the findings. (C) 2018 Elsevier Inc. All rights reserved.en_US
dc.language.isoenen_US
dc.publisherW B SAUNDERS CO-ELSEVIER INCen_US
dc.subjectTraumatic brain injuryen_US
dc.subjectErythropoietinen_US
dc.subjectMeta-analysisen_US
dc.subjectPrognosisen_US
dc.titleEfficacy and safety of erythropoietin in patients with traumatic brain injury: A systematic review and meta-analysisen_US
dc.typeArticleen_US
dc.relation.no6-
dc.relation.volume37-
dc.identifier.doi10.1016/j.ajem.2018.08.072-
dc.relation.page1101-1107-
dc.relation.journalAMERICAN JOURNAL OF EMERGENCY MEDICINE-
dc.contributor.googleauthorLee, Juncheol-
dc.contributor.googleauthorCho, Youngsuk-
dc.contributor.googleauthorChoi, Kyu-Sun-
dc.contributor.googleauthorKim, Wonhee-
dc.contributor.googleauthorJang, Bo-Hyoung-
dc.contributor.googleauthorShin, Hyungoo-
dc.contributor.googleauthorAhn, Chiwon-
dc.contributor.googleauthorLim, Tae Ho-
dc.contributor.googleauthorYi, Hyeong-Joong-
dc.relation.code2019041404-
dc.sector.campusS-
dc.sector.daehakCOLLEGE OF MEDICINE[S]-
dc.sector.departmentDEPARTMENT OF MEDICINE-
dc.identifier.pidvertex09-
Appears in Collections:
COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE